Center for Biomaterials, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Division of Bio-Medical Science and Technology, KIST School, University of Science and Technology (UST), Seoul, 02792, Republic of Korea.
Adv Sci (Weinh). 2024 May;11(18):e2305852. doi: 10.1002/advs.202305852. Epub 2024 Mar 12.
Herein, a novel extracellular matrix (ECM) hydrogel is proposed fabricated solely from decellularized, human fibroblast-derived matrix (FDM) toward advanced wound healing. This FDM-gel is physically very stable and viscoelastic, while preserving the natural ECM diversity and various bioactive factors. Subcutaneously transplanted FDM-gel provided a permissive environment for innate immune cells infiltration. Compared to collagen hydrogel, excellent wound healing indications of FDM-gel treated in the full-thickness wounds are noticed, particularly hair follicle formation via highly upregulated β-catenin. Sequential analysis of the regenerated wound tissues disclosed that FDM-gel significantly alleviated pro-inflammatory cytokine and promoted M2-like macrophages, along with significantly elevated vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) level. A mechanistic study demonstrated that macrophages-FDM interactions through cell surface integrins α5β1 and α1β1 resulted in significant production of VEGF and bFGF, increased Akt phosphorylation, and upregulated matrix metalloproteinase-9 activity. Interestingly, blocking such interactions using specific inhibitors (ATN161 for α5β1 and obtustatin for α1β1) negatively affected those pro-healing growth factors secretion. Macrophages depletion animal model significantly attenuated the healing effect of FDM-gel. This study demonstrates that the FDM-gel is an excellent immunomodulatory material that is permissive for host cells infiltration, resorbable with time, and interactive with macrophages, where it thus enables regenerative matrix remodeling toward a complete wound healing.
本文提出了一种新型细胞外基质(ECM)水凝胶,它仅由脱细胞化的人成纤维细胞衍生基质(FDM)制成,旨在实现先进的伤口愈合。这种 FDM 水凝胶在物理上非常稳定且具有粘弹性,同时保留了天然 ECM 的多样性和各种生物活性因子。皮下移植的 FDM 水凝胶为固有免疫细胞的浸润提供了一个许可的环境。与胶原水凝胶相比,在全层伤口中 FDM 水凝胶处理的伤口愈合指标明显更好,特别是通过高度上调β-连环蛋白形成毛囊。对再生伤口组织的连续分析表明,FDM 水凝胶显著减轻了促炎细胞因子的作用,并促进了 M2 样巨噬细胞的生成,同时还显著提高了血管内皮生长因子(VEGF)和碱性成纤维细胞生长因子(bFGF)的水平。一项机制研究表明,巨噬细胞-FDM 通过细胞表面整合素 α5β1 和 α1β1 的相互作用,导致 VEGF 和 bFGF 的大量产生,增加 Akt 磷酸化,并上调基质金属蛋白酶-9 的活性。有趣的是,使用特异性抑制剂(ATN161 用于 α5β1 和 obtustatin 用于 α1β1)阻断这些相互作用会对这些促愈合生长因子的分泌产生负面影响。巨噬细胞耗竭动物模型显著减弱了 FDM 水凝胶的愈合效果。本研究表明,FDM 水凝胶是一种出色的免疫调节材料,它允许宿主细胞浸润、可随时间吸收,并与巨噬细胞相互作用,从而实现再生基质重塑,以实现完全的伤口愈合。